

(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive reported a significant increase in revenue in its full-year results on Frid...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.


(Alliance News - Genedrive PLC on Friday said its loss widened during its most recent financial year, as its expenses ramped up.


(Sharecast News) - Genedrive revealed on Thursday that chairman Ian Gilham had acquired 1.0m shares in the AIM-listed pharmacogenetic testing company.


(Sharecast News) - Pharmacogenetic testing firm Genedrive said on Monday that it has made the first UK commercial sales of its CYP2C19-ID testing kit.


(Alliance News) - Stocks in London are called to open higher, as some calm spreads over markets a week after the global sell-off which shook investors...